Navigation Links
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Date:4/8/2008

In Period B of the study, patients who completed Period A and achieved an ACR Pedi 30 response were eligible to enter this six-month, double-blind phase. Patients entering Period B (n=122) were randomized to remain on ORENCIA (n=60) or receive placebo (n=62) for six months.

The primary endpoint of the study was time to occurrence of disease flare. Disease flare was defined as a greater than or equal to 30 percent worsening in at least three of the six JIA core set variables with greater than or equal to 30 percent improvement in not more than one of the six JIA core set variables; greater than or equal to two centimeters of worsening of the Physician or Parent Global Assessment was necessary if used as one of the three JIA core set variables used to define flare, and worsening in greater than or equal to two joints was necessary if the number of active joints or joints with limitation of motion was used as one of the three JIA core set variables used to define flare.

Efficacy results included:

-- Time difference to occurrence of disease flare was statistically

significant based on the log-rank test in patients treated with

placebo compared with ORENCIA(R) (abatacept)

(p-value equals 0.0002).

-- Patients treated with ORENCIA experienced significantly fewer disease

flares compared to placebo-treated patients (20 percent vs. 53

percent, respectively, p-value less than 0.001).

-- The risk of disease flare among patients continuing on ORENCIA was

less than one-third than that for patients who withdrew from ORENCIA

treatment [Hazard Ratio: 0.31, 95 percent CI (0.16, 0.59)].

In patients receiving ORENCIA treatment throughout the study (Period A, Period B and the open-label extension Period C), the proportion of ACR Pedi 30, 50 and 70 responders remained consistent through one year.

In both the open-label, lead-in (Period A) and double-blind (Pe
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
5. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
6. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
7. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
8. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
11. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- Dynatronics Corporation (NASDAQ: DYNT ) today announced that ... Company,s Board of Directors effective March 23, 2015, to fill ... board member Joseph Barton .  "The ... Directors represents an important step forward for the company," said ... "Rich is a proven leader and is well-known for his ...
(Date:3/27/2015)... 27, 2015  Holographic Optical Technologies of ... holographic medical imaging, is entering the world of consumer ... on April 20 th , 2015, the campaign will ... 8-inch and 22-inch displays will allow consumers to view ... time. In addition to the two displays, the company ...
(Date:3/27/2015)... , March 27, 2015  Victoria Vein & Surgery Clinic ... the Astanza Duality laser in Victoria, Texas ... as well as advanced laser treatments for a variety of ... tattoo industry to provide more services for their patients. Since ... many Victoria residents get rid of ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2
... July 19, 2011 Jonah and Dina Shacknai today issued the ... of police reports by the Paradise Valley Police Department: ... us had hoped, it did produce a wonderful son, Max, whom ... police reports are not reflective of the totality or the precise ...
... power of cosmetic lasers has grown by leaps and bounds ... laser treatments were first used, they were ablative lasers that ... younger skin below. However, the drawback to these early cosmetic ... of the skin down, which they did by stripping the ...
Cached Medicine Technology:Renaissance Laser and Vein Institute Specializes in Revolutionary Laser Treatments for a Variety of Cosmetic Applications 2
(Date:3/28/2015)... March 28, 2015 India Network ... is made available to all visitors who purchase the ... All members are encouraged to purchase the insurance program ... lack of proper coverage for pre-existing medical conditions. Parents ... or two medical conditions with serious consequences to their ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 Pitching ... with a history of shoulder and elbow injuries, according to ... Sports Medicine’s ( AOSSM ) Specialty Day. , “Our findings ... with a 20% increase in likelihood of a history of ... associated with a 12% increase likelihood of a history of ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... may not be necessary, according to research presented today ... AOSSM ) Specialty Day. , “Our study compared results ... 25 who underwent an additional glenohumeral joint capsule release ... commented George Murrell MD, PhD, lead author from St. ...
(Date:3/28/2015)... March 28, 2015 Andrew Hawley of Vintage ... Who psychedelic concert posters. The Who and the Doors played ... August 2, 1968. According to Hawley, “The Who toured the ... halls and college campuses. Perhaps the most famous Who poster ... Morrison and the Doors on August 2, 1968 at the ...
(Date:3/28/2015)... 28, 2015 Healthpointe’s otolaryngologists, medical practitioners ... throat disorders, are now offering a wide variety ... which is characterized by the presence of phantom sounds ... people, tinnitus is a prevalent symptom that can arise ... is non-fatal, tinnitus can impede a person’s quality of ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2
... Ingenious Med (IM), the leader in,inpatient practice ... groups and meet the increasing demand for a ... wide. Specialists are,quickly becoming an ever-growing segment of ... that Arizona based Cardiovascular Associates of Mesa,(CAM) joins ...
... Ill., Nov. 5 The American Veterinary,Medical Association (AVMA) ... consider and vote on Proposition 2. Now that it,s ... animal welfare scientists --,must be employed to ensure its ... "It was encouraging to see voters in California take ...
... the key factors that health professionals need to be aware ... Researchers from the University of Sheffield, UK, found considerable differences ... 16 viewed a series of sexual scenarios. , "The ... likely to see their partner,s point of view and were ...
... (Nasdaq: ALSE ) today announced that Peter ... present Monday,November 10th at 2:00pm ET at Rodman ... Palace Hotel in New York providing an overview ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO ), ...
... Select AT&T Phones Into Versatile Fitness Training and ... Performance Tracking Tools, ... off the stress and creeping pounds that often come with the,holidays, ... ) today announced,the availability of the AllSport GPS(TM) application that lets ...
... S2383 to be used as a flavor ingredient in commercial ... products in the U.S. and ... SNMX ), a leading company focused on using proprietary technologies,to ... supply industries, announced today that it has been notified by,the Flavor ...
Cached Medicine News:Health News:Ingenious Med Adds Specialists to Clientele, Cardiovascular Group 2Health News:AVMA: Veterinarians Need to Be Included in Proposition 2 Implementation 2Health News:Alcohol advice needs to play a greater role in sex education for teenagers 2Health News:Alcohol advice needs to play a greater role in sex education for teenagers 3Health News:Alseres Pharmaceuticals, Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2Health News:Trimble and AT&T Make It Easier to Stay Fit and Healthy With New Application for AT&T GPS-Enabled Mobile Phones 2Health News:Trimble and AT&T Make It Easier to Stay Fit and Healthy With New Application for AT&T GPS-Enabled Mobile Phones 3Health News:Trimble and AT&T Make It Easier to Stay Fit and Healthy With New Application for AT&T GPS-Enabled Mobile Phones 4Health News:SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER 2Health News:SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER 3Health News:SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: